Blue Vision A/S EBIT

As of the most recent data (June 2026), BLVIS-A.CO shows a EBIT of $-18M. That compares with $-26M in the prior-year period — up 30.8% year over year. That is below the Healthcare sector average of $1.9T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLVIS-A.CO's EBIT is now $-18M (was $-26M) — a 30.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Blue Vision A/S is outperforming or lagging.

The Healthcare sector average EBIT is about $1.9T. Blue Vision A/S is at $-18M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BLVIS-A.CO stacks up against individual peers as well.

Tracking BLVIS-A.CO's ebit over time shows whether Blue Vision A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $-18M That compares with $-26M in the prior-year period — up 30.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Blue Vision A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-18M) with ownership activity and broader fundamentals.